Moyamoya disease and systemic sclerosis (MoSys syndrome): a combination of two rare entities: comment to the authors

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):216. Epub 2017 Feb 23.
No abstract available

MeSH terms

  • Female
  • Humans
  • Moyamoya Disease / drug therapy*
  • Rituximab / therapeutic use
  • Scleroderma, Systemic / drug therapy*

Substances

  • Rituximab